Skip to Main Content

Paper Details

Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.
J Urol
6
2021
Author NameAffiliation
Craig Gedye
Michiel S van der HeijdenThe Netherlands Cancer Institute
Cora N SternbergSan Camillo and Forlanini Hospitals, Italy (present address: Englander Institute for Precision Medicine, Meyer Cancer Center
  • 1 - 3

Datasets

Release 1.2